How do they prevent raising more cash at this point. FDA approval so far away after having to run “healthy volunteer pharmacokinetic study” - trying to submit by end of year. They do not have enough cash to make it through FDA decision - 2nd quarter 2022 at the earliest.
From PR As of June 30, 2021, cash and cash equivalents were $22.1 million, compared with $35.3 million as of December 31, 2020.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.